- Home
- ESQ vs EVMN Comparison
ESQ vs EVMN Comparison
Compare ESQ & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESQ | EVMN |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 944.4M | 892.4M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | ESQ | EVMN |
|---|---|---|
| Price | $103.09 | $25.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $118.00 | $44.17 |
| AVG Volume (30 Days) | 61.8K | ★ 971.0K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.79% | N/A |
| EPS Growth | ★ 4.68 | N/A |
| EPS | ★ 4.32 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $22.47 | $89.43 |
| Revenue Next Year | $10.25 | N/A |
| P/E Ratio | $23.36 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $69.14 | $13.89 |
| 52 Week High | $119.86 | $33.20 |
Technical Indicators
Market Signals| Indicator | ESQ | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 52.51 |
| Support Level | $99.97 | $15.80 |
| Resistance Level | $103.44 | $33.20 |
| Average True Range (ATR) | 4.25 | 3.72 |
| MACD | -0.93 | -0.38 |
| Stochastic Oscillator | 19.65 | 34.61 |
Price Performance
Historical ComparisonAbout ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.